EcoDrugPlus

Nucleotide-Binding Oligomerization Domain-Containing Protein 2-Like

Ensembl ID : ENSNBRG00000009217
Gene Symbol: LOC102779389
3 Cross references
165 Possible Orthologues:

Nucleotide-Binding Oligomerization Domain-Containing Protein 2-Like

Ensembl ID : ENSNBRG00000000093
Gene Symbol: LOC102799400
4 Cross references
165 Possible Orthologues:

Opioid Receptor Kappa 1

Ensembl ID : ENSNBRG00000014072
Gene Symbol: OPRK1
3 Cross references
197 Possible Orthologues:

Opioid Receptor, Delta 1b

Ensembl ID : ENSNBRG00000021676
Gene Symbol: OPRD1B
1 Cross references
174 Possible Orthologues:

Orexin Receptor Type 2-Like

Ensembl ID : ENSNBRG00000012348
Gene Symbol: LOC102781101
3 Cross references
203 Possible Orthologues:

Oxysterols Receptor Lxr-Alpha-Like

Ensembl ID : ENSNBRG00000019379
Gene Symbol: LOC102777562
3 Cross references
391 Possible Orthologues:

Oxytocin Receptor

Ensembl ID : ENSNBRG00000017883
Gene Symbol: OXTR
3 Cross references
183 Possible Orthologues:

Oxytocin Receptor A

Ensembl ID : ENSNBRG00000004778
Gene Symbol: OXTRA
1 Cross references
191 Possible Orthologues:

Parathyroid Hormone/parathyroid Hormone-Related Peptide Receptor-Like

Ensembl ID : ENSNBRG00000004951
Gene Symbol: LOC102780601
3 Cross references
196 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Gamma

Ensembl ID : ENSNBRG00000021527
Gene Symbol: PPARG
4 Cross references
386 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Alpha-Like

Ensembl ID : ENSNBRG00000018696
Gene Symbol: LOC102786309
3 Cross references
396 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Alpha-Like

Ensembl ID : ENSNBRG00000023390
Gene Symbol: LOC102799911
3 Cross references
383 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).